Skip to main content
Top
Published in: BMC Pediatrics 1/2011

Open Access 01-12-2011 | Case report

Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis

Authors: Verena Wiegering, Judith Schick, Meinrad Beer, Benedikt Weissbrich, Stefan Gattenlöhner, Hermann J Girschick, Johannes Liese, Paul G Schlegel, Matthias Eyrich

Published in: BMC Pediatrics | Issue 1/2011

Login to get access

Abstract

Background

Infection with varicella-zoster virus (VZV) contemporaneously with malignant disease or immunosuppression represents a particular challenge and requires individualized decisions and treatment. Although the increasing use of varicella-vaccines in the general population and rapid initiation of VZV-immunoglobulins and acyclovir in case of exposure has been beneficial for some patients, immunocompromised individuals are still at risk for unfavourable courses.

Methods

In this single center, 6-year analysis we review incidence, hospitalization and complication rates of VZV-infections in our center and compare them to published data. Furthermore, we report three instructive cases.

Results

Hospitalization rate of referred children with VZV-infections was 45%, among these 17% with malignancies and 9% under immunosuppressive therapy. Rate of complications was not elevated in these two high-risk cohorts, but one ALL-patient died due to VZV-related complications. We report one 4-year old boy with initial diagnosis of acute lymphoblastic leukemia who showed a rapidly fatal outcome of his simultaneous varicella-infection, one 1.8-year old boy with an identical situation but a mild course of his disease, and an 8.5-year old boy with a steroid-dependent nephrotic syndrome. This boy developed severe hepatic involvement during his varicella-infection but responded to immediate withdrawl of steroids and administration of acyclovir plus single-dose cidofovir after nonresponse to acyclovir after 48 h.

Conclusion

Our data show that patients with malignant diseases or immunosuppressive therapy should be hospitalized and treated immediately with antiviral agents. Despite these measures the course of VZV-infections can be highly variable in these patients. We discuss aids to individual decision-making for these difficult situations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R: The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008, 27 (2): 119-124. 10.1097/INF.0b013e3181586665.CrossRefPubMed Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R: The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008, 27 (2): 119-124. 10.1097/INF.0b013e3181586665.CrossRefPubMed
2.
go back to reference Rack AL, Grote V, Streng A, Belohradsky BH, Heinen F, von Kries R, Liese JG: Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010, 42 (1): 40-48. 10.1016/j.pediatrneurol.2009.07.012.CrossRefPubMed Rack AL, Grote V, Streng A, Belohradsky BH, Heinen F, von Kries R, Liese JG: Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010, 42 (1): 40-48. 10.1016/j.pediatrneurol.2009.07.012.CrossRefPubMed
3.
go back to reference Feldman S, Hughes WT, Daniel CB: Varicella in children with cancer: Seventy-seven cases. Pediatrics. 1975, 56 (3): 388-397.PubMed Feldman S, Hughes WT, Daniel CB: Varicella in children with cancer: Seventy-seven cases. Pediatrics. 1975, 56 (3): 388-397.PubMed
4.
go back to reference Katsimpardi K, Papadakis V, Pangalis A, Parcharidou A, Panagiotou JP, Soutis M, Papandreou E, Polychronopoulou S, Haidas S: Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Support Care Cancer. 2006, 14 (3): 277-284. 10.1007/s00520-005-0884-6.CrossRefPubMed Katsimpardi K, Papadakis V, Pangalis A, Parcharidou A, Panagiotou JP, Soutis M, Papandreou E, Polychronopoulou S, Haidas S: Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Support Care Cancer. 2006, 14 (3): 277-284. 10.1007/s00520-005-0884-6.CrossRefPubMed
5.
go back to reference Matsuzaki A, Suminoe A, Koga Y, Kusuhara K, Hara T, Ogata R, Sata T: Fatal visceral varicella-zoster virus infection without skin involvement in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2008, 25 (3): 237-242. 10.1080/08880010801938215.CrossRefPubMed Matsuzaki A, Suminoe A, Koga Y, Kusuhara K, Hara T, Ogata R, Sata T: Fatal visceral varicella-zoster virus infection without skin involvement in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2008, 25 (3): 237-242. 10.1080/08880010801938215.CrossRefPubMed
6.
go back to reference Meir HM, Balawi IA, Meer HM, Nayel H, Al-Mobarak MF: Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy. Saudi Med J. 2001, 22 (5): 423-427.PubMed Meir HM, Balawi IA, Meer HM, Nayel H, Al-Mobarak MF: Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy. Saudi Med J. 2001, 22 (5): 423-427.PubMed
7.
go back to reference Dits H, Frans E, Wilmer A, Van Ranst M, Fevery J, Bobbaers H: Varicella-zoster virus infection associated with acute liver failure. Clin Infect Dis. 1998, 27 (1): 209-210. 10.1086/514613.CrossRefPubMed Dits H, Frans E, Wilmer A, Van Ranst M, Fevery J, Bobbaers H: Varicella-zoster virus infection associated with acute liver failure. Clin Infect Dis. 1998, 27 (1): 209-210. 10.1086/514613.CrossRefPubMed
8.
go back to reference Muller I, Aepinus C, Beck R, Bultmann B, Niethammer D, Klingebiel T: Noncutaneous varicella-zoster virus (VZV) infection with fatal liver failure in a child with acute lymphoblastic leukemia (ALL). Med Pediatr Oncol. 2001, 37 (2): 145-147. 10.1002/mpo.1186.CrossRefPubMed Muller I, Aepinus C, Beck R, Bultmann B, Niethammer D, Klingebiel T: Noncutaneous varicella-zoster virus (VZV) infection with fatal liver failure in a child with acute lymphoblastic leukemia (ALL). Med Pediatr Oncol. 2001, 37 (2): 145-147. 10.1002/mpo.1186.CrossRefPubMed
9.
go back to reference Snoeck R, Andrei G, De Clercq E: Novel agents for the therapy of varicella-zoster virus infections. Expert Opin Investig Drugs. 2000, 9 (8): 1743-1751. 10.1517/13543784.9.8.1743.CrossRefPubMed Snoeck R, Andrei G, De Clercq E: Novel agents for the therapy of varicella-zoster virus infections. Expert Opin Investig Drugs. 2000, 9 (8): 1743-1751. 10.1517/13543784.9.8.1743.CrossRefPubMed
10.
go back to reference De Clercq E: Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev. 2003, 16 (4): 569-596. 10.1128/CMR.16.4.569-596.2003.CrossRefPubMedPubMedCentral De Clercq E: Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev. 2003, 16 (4): 569-596. 10.1128/CMR.16.4.569-596.2003.CrossRefPubMedPubMedCentral
11.
go back to reference Folatre I, Zolezzi P, Schmidt D, Marin F, Tager M: [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old]. Rev Med Chil. 2003, 131 (7): 759-764.CrossRefPubMed Folatre I, Zolezzi P, Schmidt D, Marin F, Tager M: [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old]. Rev Med Chil. 2003, 131 (7): 759-764.CrossRefPubMed
12.
go back to reference Morfin F, Frobert E, Thouvenot D: [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Ann Biol Clin (Paris). 2003, 61 (1): 33-40. Morfin F, Frobert E, Thouvenot D: [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Ann Biol Clin (Paris). 2003, 61 (1): 33-40.
13.
go back to reference Rowland P, Wald ER, Mirro JR, Yunis E, Albo VC, Wollman MR, Blatt J: Progressive varicella presenting with pain and minimal skin involvement in children with acute lymphoblastic leukemia. J Clin Oncol. 1995, 13 (7): 1697-1703.PubMed Rowland P, Wald ER, Mirro JR, Yunis E, Albo VC, Wollman MR, Blatt J: Progressive varicella presenting with pain and minimal skin involvement in children with acute lymphoblastic leukemia. J Clin Oncol. 1995, 13 (7): 1697-1703.PubMed
14.
go back to reference Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M, Machaczka M, Bierings M, Bosi A, Gratecos N, et al: Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003, 31 (6): 481-486. 10.1038/sj.bmt.1703798.CrossRefPubMed Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M, Machaczka M, Bierings M, Bosi A, Gratecos N, et al: Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003, 31 (6): 481-486. 10.1038/sj.bmt.1703798.CrossRefPubMed
15.
go back to reference Andrei G, De Clercq E, Snoeck R: In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?. Antiviral Res. 2004, 61 (3): 181-187. 10.1016/j.antiviral.2003.10.003.CrossRefPubMed Andrei G, De Clercq E, Snoeck R: In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?. Antiviral Res. 2004, 61 (3): 181-187. 10.1016/j.antiviral.2003.10.003.CrossRefPubMed
16.
go back to reference Ventura GJ, Hester JP, Smith TL, Keating MJ: Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol. 1988, 27 (1): 34-37. 10.1002/ajh.2830270109.CrossRefPubMed Ventura GJ, Hester JP, Smith TL, Keating MJ: Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol. 1988, 27 (1): 34-37. 10.1002/ajh.2830270109.CrossRefPubMed
17.
go back to reference Siedler A, Arndt U: Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010, 15 (13): Siedler A, Arndt U: Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010, 15 (13):
Metadata
Title
Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis
Authors
Verena Wiegering
Judith Schick
Meinrad Beer
Benedikt Weissbrich
Stefan Gattenlöhner
Hermann J Girschick
Johannes Liese
Paul G Schlegel
Matthias Eyrich
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2011
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-11-31

Other articles of this Issue 1/2011

BMC Pediatrics 1/2011 Go to the issue